Isoprostane as a promising biomarker in pulmonary arterial hypertension: Preanalytical and analytical viewpoints. Response to letter to the editor

被引：1
|
作者：
Zhang, Rui [1 ]
Jing, Zhi-Cheng [2 ,3 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Cardiopulm Circulat, Shanghai 200092, Peoples R China
[2] Peking Union Med Coll, Thrombosis & Vasc Med Ctr, State Key Lab Cardiovasc Dis, Fu Wai Hosp, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Beijing 100730, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 177卷 / 02期
关键词：
15-F2t-IsoP; Idiopathic pulmonary arterial hypertension; Prognosis; Biomarkers; Preanalytical and analytical; MASS-SPECTROMETRY; PLASMA SAMPLES; F-2-ISOPROSTANES; QUANTIFICATION; 15-F-2T-ISOPROSTANE; STRESS; URINE;
D O I：
10.1016/j.ijcard.2014.09.122
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：632 / 633
页数：2
相关论文
共 38 条
  • [31] Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle"
    van der Bruggen, Cathelijne E.
    Happe, Chris M.
    Goumans, Marie-Jose
    Bogaard, Harm Jan
    Noordegraaf, Anton Vonk
    de Man, Frances S.
    CIRCULATION, 2016, 134 (09) : E117 - E118
  • [32] Response by Tello et al to Letter Regarding Article, "Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension"
    Tello, Khodr
    Ghofrani, Hossein A.
    Seeger, Werner
    Richter, Manuel J.
    Naeije, Robert
    CIRCULATION-CARDIOVASCULAR IMAGING, 2019, 12 (11)
  • [33] Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)"
    Preston, Ioana R.
    Roberts, Kari E.
    Miller, Dave P.
    Sen, Ginny P.
    Selej, Mona
    Benton, Wade W.
    Hill, Nicholas S.
    Farber, Harrison W.
    CIRCULATION, 2016, 133 (20) : e662 - e662
  • [34] Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension"
    Hadinnapola, Charaka
    Graf, Stefan
    Morrell, Nicholas W.
    CIRCULATION, 2018, 137 (22) : 2413 - 2414
  • [35] Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17
    Beghetti, Maurice
    Ivy, Dunbar
    Scott, Nicola
    Machlitt-Northen, Sandra
    Lukas, Mary Ann
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (05) : 2453 - 2454
  • [36] Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17
    Maurice Beghetti
    Dunbar Ivy
    Nicola Scott
    Sandra Machlitt-Northen
    Mary Ann Lukas
    European Journal of Pediatrics, 2023, 182 : 2453 - 2454
  • [37] Correspondence, letter to the editor regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17
    Li, Li
    Ning, Jing
    Ma, Shixun
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (05) : 2455 - 2455
  • [38] Correspondence, letter to the editor regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17
    Li Li
    Jing Ning
    Shixun Ma
    European Journal of Pediatrics, 2023, 182 : 2455 - 2455
1234